Meng Lei bought DNTH

January 22, 2024 · Form 4 insider transaction

Meng Lei bought 1,500,000 shares of Dianthus Therapeutics, Inc. at $12.00 per share, a transaction worth $18.00M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,500,000
Price
$12.00
Total value
$18.00M
InsiderMeng Lei
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 22, 2024
Filing dateJanuary 24, 2024
Shares owned after2,717,554
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of an aggregate of 1,500,000 shares of common stock purchased by clients of Avidity Partners Management LP from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").; The reported securities are held by clients of Avidity Partners Management LP and may be deemed to beneficially owned by (i) Avidity Partners Management LP, (ii) Avidity Partners Management (GP) LLC, the general partner of Avidity Partners Management LP and (iii) each of David Witzke and Michael Gregory, the managing members of Avidity Partners Management (GP) LLC. Lei Meng, an employee of Avidity Partners Management LP, is a director of the Issuer. Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Mr. Witzke and Mr. Gregory may be considered directors by deputization due to their affiliation with Ms. Meng. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its, his or her pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR